Pressure-Volume Loop During High-Risk PCI
Pressure-Volume Loop During PCI: Real-Time Left Ventricular Pressure-Volume Analysis in High-Risk PCI
1 other identifier
observational
10
1 country
1
Brief Summary
This study will examine the physiologic effects on loading conditions and contractility of the left ventricle during high-risk primary coronary intervention (HRPCI) in the Cardiac Cath Lab. This will be performed through analysis of real-time left ventricular (LV) pressure-volume loops (PVL) by continuously recording PVL during HRPCI with the Inca® Pressure-Volume Loop System that will be temporarily placed in the left ventricle during the procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2020
CompletedFirst Posted
Study publicly available on registry
December 23, 2020
CompletedStudy Start
First participant enrolled
April 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 12, 2024
CompletedNovember 14, 2024
November 1, 2024
1.6 years
December 18, 2020
November 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Changes in left ventricular end diastolic pressure (LVEDP).
Measured changes in left ventricular end diastolic pressure (LVEDP) as measured real-time by the Inca PV-Loop system.
Immediate (during PCI).
Changes in left ventricular end systolic pressure.
Measured changes in left ventricular end systolic pressure as measured real-time by the Inca PV-Loop system.
Immediate (during PCI).
Changes in left ventricular compliance.
Measured changes in left ventricular compliance as measured real-time by the Inca PV-Loop system.
Immediate (during PCI).
Interventions
Percutaneous coronary interventions (PCI) deemed high risk based on patient-related risk features, hemodynamic criteria, clinical presentation and complexity of coronary anatomy.
Eligibility Criteria
Ten adult patients with planned elective HRPCI procedures. Procedures are deemed high-risk based on patient-related risk features, hemodynamic criteria, clinical presentation and complexity of coronary anatomy. Patient-related high risk features include low left ventricle ejection fraction (LVEF), advanced age, and comorbidities including advanced kidney disease, peripheral and cerebral vascular disease. High-risk baseline hemodynamic features include hypotension, severely elevated LVEDP, and severely depressed cardiac output. Coronary anatomy complexity criteria include left main coronary artery involvement, multi- vessel CAD, and severely calcified coronary lesions requiring atherectomy. The decision to use an MCS device for hemodynamic support will be planned, not randomized, as it will be made prior to patient enrollment based on the clinical judgment of the treating physician.
You may qualify if:
- Adult patients (18 years and older) with known coronary artery disease and planned elective HRPCI procedures.
You may not qualify if:
- Any patient not considered appropriate for elective HRPCI procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Henry Ford Health Systemlead
- Abiomed Inc.collaborator
Study Sites (1)
Henry Ford Hospital
Detroit, Michigan, 48202, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William O'Neill, MD
Henry Ford Health System
- STUDY DIRECTOR
Mohammad Alqarqaz, MD
Henry Ford Health System
- STUDY DIRECTOR
Mir Babar Basir, DO
Henry Ford Health System
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Center for Structural Heart Disease
Study Record Dates
First Submitted
December 18, 2020
First Posted
December 23, 2020
Study Start
April 19, 2021
Primary Completion
December 1, 2022
Study Completion
September 12, 2024
Last Updated
November 14, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share